Skip to main content
Home
Loading...
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube

Menu top

  • Assistance

User account menu

  • Log in
Home

Main navigation

  • Home
  • Programme
Menu Login
Close

Main navigation mobile

  • Home
  • Programme

Menu top

  • Assistance
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
Filters
Filters Close
Poster topics
Poster available until
  • x Monday 29 June 2026 (3)
  • Until platform closure (6)
Poster categories
  • Thematic Poster Session (3)
keywords
Session Reference
  • L-TPS01 (2)
  • L-TPS02 (1)
  • L-TPS03 (5)
  • L-TPS04 (1)
  • L-TPS06 (1)
  • L-TPS07 (6)
  • L-TPS08 (2)
  • L-TPS09 (3)
  • L-TPS10 (4)
  • L-TPS11 (5)
  • L-TPS12 (2)
  • L-TPS13 (4)
  • L-TPS14 (1)
  • L-TPS15 (2)
  • L-TPS16 (2)
  • L-TPS17 (4)
  • L-TPS18 (4)
  • L-TPS20 (2)
  • L-TPS22 (1)
  • L-TPS23 (1)
  • L-TPS24 (4)
  • L-TPS25 (3)
  • TPS01 (5)
  • TPS02 (2)
  • TPS03 (4)
  • TPS04 (6)
  • TPS05 (3)
  • TPS06 (4)
  • TPS07 (3)
  • TPS08 (3)
  • TPS09 (2)
  • TPS10 (6)
  • TPS11 (7)
  • TPS12 (6)
  • TPS13 (1)
  • TPS14 (6)
  • TPS15 (5)
  • TPS16 (3)
  • TPS17 (4)
  • TPS18 (2)
  • TPS20 (5)
  • TPS21 (4)
  • TPS22 (4)
  • x TPS23 (3)
  • TPS24 (4)
  • TPS25 (3)
  • TPS26 (7)
  • TPS29 (1)
  • TPS30 (2)
  • TPS31 (5)
  • TPS33 (2)
  • TPS34 (5)
  • TPS35 (4)
  • TPS36 (3)
  • TPS37 (2)
  • TPS38 (4)
  • TPS39 (3)
  • TPS40 (6)
  • TPS41 (4)
  • TPS42 (3)
  • TPS43 (3)
  • TPS44 (3)
  • TPS45 (1)
  • TPS46 (1)
  • TPS47 (3)
  • TPS48 (1)
  • TPS49 (1)
  • TPS50 (4)
  • TPS51 (6)
  • TPS52 (6)
  • TPS53 (6)
  • TPS54 (3)
  • TPS55 (6)
  • TPS56 (3)
  • TPS57 (1)
  • TPS60 (3)
  • TPS61 (5)
  • TPS62 (3)
  • TPS63 (2)
  • TPS64 (3)
  • TPS65 (1)
  • TPS66 (6)
  • TPS67 (3)
  • TPS68 (6)
  • TPS69 (1)
  • TPS70 (1)
  • TPS71 (1)
  • TPS72 (2)
  • TPS73 (3)
  • TPS74 (2)
  • TPS75 (6)
  • TPS76 (1)
  • TPS77 (1)
  • TPS78 (2)
  • TPS79 (11)
  • TPS80 (3)
  • TPS82 (7)
  • TPS83 (2)
  • TPS84 (4)
  • TPS85 (3)
  • TPS86 (1)
3 results
Thumbnail

D1.446 - Lebrikizumab in patients with urticarial vasculitis - a case series

Thumbnail

D1.441 - A Bispecific Antibody Targeting IL13 and IL31 for the Treatment of Inflammatory Skin Diseases

Thumbnail

D1.444 - Dual Blockade of IL22 and IL23 with a bispecific antibody: A Promising Strategy for the Treatment of Psoriasis and Other Autoimmune Skin Disorders

Download the app
The congress at your fingertips

Available on

App Store Google Play
QR Code Download
Mobile App Schedule page
Mobile App Home page
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
© 2026 EAACI
Made with   by CYIM